Oncobiologics (ONSIU) is Initiated by Barclays to Overweight, Price Target at $11

Oncobiologics (ONSIU) was Initiated by Barclays to “Overweight” and the brokerage firm has set the Price Target at $11. Barclays advised their investors in a research report released on Jun 7, 2016.


Leave a Reply

Oncobiologics - Is it time to Sell?

Top Brokerage Firms are advising their investors on Oncobiologics. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.